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Dear Editor,
Capgras syndrome (CS), late-onset schizophrenia (LOS) and 
refractory schizophrenia are relatively common conditions in 
psychiatric practice. However, the combination of these three 
conditions in a single case is a very rare event and so far seldom 
reported1. We report a case of a patient with LOS presenting with of 
CS and super-refractoriness since its first crisis.
A 53-year-old woman was admitted to a psychiatric hospital in 
an acute psychotic episode. On admission, she was convicted that her 
family had been enrolled in a plot in which they were replaced by 
lookalikes. This was the first time she presented psychotic symptoms 
and no treatment had yet been instituted. Physical examination, 
laboratory tests and brain MRI presented no abnormalities. She 
was diagnosed with late-onset schizophrenia (LOS) and Capgras 
Syndrome (CS). Haloperidol, risperidone and olanzapine, all in 
monotherapy, were tried at optimal doses for a period of four weeks 
each, with unsatisfactory response. Then, clozapine was started in 
a dose up to 425 mg daily leading to serum levels of 587 ng/mL 
(reference value: 50 to 700 ng/mL), with no clinical signs of response 
after 33 weeks. Subsequently, electroconvulsive therapy was prescribed 
as adjuvant therapy to clozapine. After 17 bitemporal sessions, 
psychosis with Capgras delusion persisted, maintaining high risk of 
aggression against her family and the need to remain hospitalized. 
Schizophrenia is a relatively common disorder in clinical 
practice. Predominantly, it onsets in adolescence or early adult years, 
however 23,5% of these patients have this condition triggered after 
40 years and are classified as LOS2. This subtype schizophrenia have a 
preponderance of cases among women and the presence of schizoid 
and paranoid personality traits are frequent2.
Several hypotheses have been proposed to understand 
schizophrenia, especially cases that occur with CS, a condition 
characterized by delusions that a close subject, usually parents 
or spouse, has been replaced by a lookalike. In CS, some studies 
indicate the affection lack when in their relatives’ presence. Delusion 
development would be an attempt to explain it3.
No complementary test is necessary for the schizophrenia 
diagnosis. In LOS, laboratory exams and brain images are advisable, 
especially in the elderly. Particularly, in this population, there is a 
higher incidence of potentially serious neurological conditions, 
such as stroke or dementia, which could also present with psychotic 
symptoms and be misdiagnosed as schizophrenia at first sight4.
Given the unsatisfactory response to two different antipsychotics, 
clozapine is an important option to be considered, despite its 
potential side effects. Nonresponders patients are classified as super-
refractory. However, the literature lacks well-designed studies with 
large enough samples to draw subsequent guidelines. Also of note, 
electroconvulsive therapy proved to be effective in association to 
clozapine5.
This case highlights the unusual combination of three different 
conditions that is rarely reported in the literature1, the occurrence of 
CS in a case of LOS and super-refractory schizophrenia since its first 
crisis. In addition, it is important to emphasize the need for more 
well-designed studies to shed light on the treatment of refractory 
schizophrenia.
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